These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 12165105

  • 21. Nongenomic actions of thyroid hormone on the heart.
    Davis PJ, Davis FB.
    Thyroid; 2002 Jun; 12(6):459-66. PubMed ID: 12165107
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Enhancement of thyroid hormone receptor isoform specificity by insertion of a distant half-site into a thyroid hormone response element.
    Zavacki AM, Zhang CY, Harney JW, Larsen PR.
    Endocrinology; 1996 Apr; 137(4):1438-46. PubMed ID: 8625922
    [Abstract] [Full Text] [Related]

  • 26. An activator protein-1 (AP-1) response element on pro alpha1(l) collagen gene is necessary for thyroid hormone-induced inhibition of promoter activity in cardiac fibroblasts.
    Lee HW, Klein LE, Raser J, Eghbali-Webb M.
    J Mol Cell Cardiol; 1998 Nov; 30(11):2495-506. PubMed ID: 9925384
    [Abstract] [Full Text] [Related]

  • 27. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
    Ye L, Li YL, Mellström K, Mellin C, Bladh LG, Koehler K, Garg N, Garcia Collazo AM, Litten C, Husman B, Persson K, Ljunggren J, Grover G, Sleph PG, George R, Malm J.
    J Med Chem; 2003 Apr 24; 46(9):1580-8. PubMed ID: 12699376
    [Abstract] [Full Text] [Related]

  • 28. Adeno-associated virus-mediated expression of thyroid hormone receptor isoforms-alpha1 and -beta1 improves contractile function in pressure overload-induced cardiac hypertrophy.
    Belke DD, Gloss B, Swanson EA, Dillmann WH.
    Endocrinology; 2007 Jun 24; 148(6):2870-7. PubMed ID: 17317766
    [Abstract] [Full Text] [Related]

  • 29. Transcription of the rat sarcoplasmic reticulum Ca2+ adenosine triphosphatase gene is increased by 3,5,3'-triiodothyronine receptor isoform-specific interactions with the myocyte-specific enhancer factor-2a.
    Moriscot AS, Sayen MR, Hartong R, Wu P, Dillmann WH.
    Endocrinology; 1997 Jan 24; 138(1):26-32. PubMed ID: 8977381
    [Abstract] [Full Text] [Related]

  • 30. Calcium is the first messenger for the action of thyroid hormone at the level of the plasma membrane: first evidence for an acute effect of thyroid hormone on calcium uptake in the heart.
    Segal J.
    Endocrinology; 1990 May 24; 126(5):2693-702. PubMed ID: 2328703
    [Abstract] [Full Text] [Related]

  • 31. Thyroid hormone increases pacemaker activity in rat neonatal atrial myocytes.
    Sun ZQ, Ojamaa K, Nakamura TY, Artman M, Klein I, Coetzee WA.
    J Mol Cell Cardiol; 2001 Apr 24; 33(4):811-24. PubMed ID: 11273733
    [Abstract] [Full Text] [Related]

  • 32. Thyroid hormone inhibits ERK phosphorylation in pressure overload-induced hypertrophied mouse hearts through a receptor-mediated mechanism.
    Suarez J, Scott BT, Suarez-Ramirez JA, Chavira CV, Dillmann WH.
    Am J Physiol Cell Physiol; 2010 Dec 24; 299(6):C1524-9. PubMed ID: 20926779
    [Abstract] [Full Text] [Related]

  • 33. Thyroid hormone action on liver, heart, and energy expenditure in thyroid hormone receptor beta-deficient mice.
    Weiss RE, Murata Y, Cua K, Hayashi Y, Seo H, Refetoff S.
    Endocrinology; 1998 Dec 24; 139(12):4945-52. PubMed ID: 9832432
    [Abstract] [Full Text] [Related]

  • 34. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone.
    Ng L, Forrest D, Haugen BR, Wood WM, Curran T.
    Mol Endocrinol; 1995 Sep 24; 9(9):1202-13. PubMed ID: 7491112
    [Abstract] [Full Text] [Related]

  • 35. [Cellular mechanisms of thyroid hormone action].
    Vinzio S, Morel O, Schlienger JL, Goichot B.
    Presse Med; 2005 Sep 24; 34(16 Pt 1):1147-52. PubMed ID: 16208263
    [Abstract] [Full Text] [Related]

  • 36. The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions.
    Brittsan AG, Kiss E, Edes I, Grupp IL, Grupp G, Kranias EG.
    J Mol Cell Cardiol; 1999 Sep 24; 31(9):1725-37. PubMed ID: 10471356
    [Abstract] [Full Text] [Related]

  • 37. Different configurations of specific thyroid hormone response elements mediate opposite effects of thyroid hormone and GC-1 on gene expression.
    Gloss B, Giannocco G, Swanson EA, Moriscot AS, Chiellini G, Scanlan T, Baxter JD, Dillmann WH.
    Endocrinology; 2005 Nov 24; 146(11):4926-33. PubMed ID: 16081636
    [Abstract] [Full Text] [Related]

  • 38. Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance.
    Miller LD, McPhie P, Suzuki H, Kato Y, Liu ET, Cheng SY.
    Genome Biol; 2004 Nov 24; 5(5):R31. PubMed ID: 15128445
    [Abstract] [Full Text] [Related]

  • 39. Mutant-selective thyromimetics for the chemical rescue of thyroid hormone receptor mutants associated with resistance to thyroid hormone.
    Shi Y, Ye H, Link KH, Putnam MC, Hubner I, Dowdell S, Koh JT.
    Biochemistry; 2005 Mar 29; 44(12):4612-26. PubMed ID: 15779888
    [Abstract] [Full Text] [Related]

  • 40. Thyroid hormone regulation of calcium cycling proteins.
    Carr AN, Kranias EG.
    Thyroid; 2002 Jun 29; 12(6):453-7. PubMed ID: 12165106
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.